Access cutting-edge breast cancer treatment through this clinical trial at a research site in Torrance. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Torrance at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This is a single arm phase II trial combination of ivonescimab and carbo-docetaxel every 3 weeks for 6 cycles in patients with early-stage triple negative breast cancer. The trial is designed to test the safety and efficacy of adding ivonescimab in patients with early TNBC undergoing neoadjuvant chemotherapy with carboplatin and docetaxel. Patients will receive ivonescimab 20 mg/kg IV on Day 1 of each cycle, and carboplatin AUC6 and docetaxel 75 mg/m2 on Day 1 of each cycle for 6 cycles. Cycles
Sponsor: Cedars-Sinai Medical Center
Check if you qualify for this breast cancer clinical trial in Torrance, CA
If you're searching for breast cancer treatment options in Torrance, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Torrance research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.